Topics in Gastrointestinal Cancer

Saturday, February 1, 2014
8:00 am – 2:00 pm
Fairmont Copley Plaza Hotel
138 St. James Avenue
Boston, MA 02116

Register Online Now


Agenda | Faculty | Credits | Registration Information Course Location 


Offered by Dana-Farber/Brigham and Women’s Cancer Center, the Massachusetts General Hospital Cancer Center, and Harvard Medical School Department of Continuing Education.

Course Overview

This annual symposium, designed for oncologists, gastroenterologists, surgeons, primary care physicians, nurse practitioners, and other interested clinicians, will share the latest information on gastrointestinal cancers.  Through lecture and case-based presentations, specialists in the field will discuss several topics including: treatment and management options for colorectal, esophageal, gastric, and pancreatic cancers; genetic testing for hereditary GI cancers; and diet and lifestyle in the prevention and treatment of gastrointestinal malignancies. 

Learning Objectives

At the conclusion of this course, attendees will be able to:

  1. Evaluate new surgical approaches for the management of esophageal, gastric, pancreatic, and colorectal cancers, and apply these procedures into routine clinical practice

  2. Recognize appropriate management and treatment options for colorectal, pancreatic, esophageal, and gastric cancers, and, where appropriate, utilize these approaches in routine clinical practice

  3. Determine when to order genetic testing for patients with suspected hereditary gastrointestinal cancers and understand methods for cancer prevention in these families

  4. Analyze the role of diet, lifestyle, and various other supplements on gastrointestinal cancer prevention and treatment and advise patients on these matters

This course is designed to enhance one or more of the following Accreditation Council of Graduate Medical Education competencies:  Patient care * Medical knowledge * Practice-based learning and improvement.

About the Gastrointestinal Cancer Centers of
Dana-Farber/Brigham and Women’s Cancer Center and
Massachusetts General Hospital Cancer Center

We offer comprehensive care for patients with gastrointestinal cancers, including cancers of the colon, rectum, stomach, esophagus, pancreas, anus, bile duct (cholangiocarcinoma), liver, gallbladder, and small bowel, as well as carcinoid and islet cell malignancies.  At each cancer center, care is provided by a multidisciplinary team that includes medical oncologists; radiation oncologists; colorectal, gastrointestinal, and oncologic surgeons; and gastroenterologists, with consultative support from gastrointestinal pathologists and gastrointestinal diagnostic and interventional radiologists.

These Harvard Medical School-affiliated centers provide the latest therapies in surgery, chemotherapy, and radiation for gastrointestinal cancers.  Both centers also have active clinical research programs exploring new drug treatments and multimodality therapies.  Genetic counseling, molecular diagnostic testing, and support services, including social work, nutrition counseling, and educational and support groups are also offered.


8:00 am
Registration Check-in and Continental Breakfast

8:25 am
Welcome and Introduction
Charles F. Fuchs, MD, MPH and Jeffrey W. Clark, MD

8:30 am
Advances in the Treatment of Esophageal and Gastric Cancer
Peter C. Enzinger, MD

9:00 am
Developing New Therapeutic Paradigms for Pancreatic Cancer
Brian M. Wolpin, MD, MPH

9:30 am
Novel Approaches to the Surgical Resection of Liver Metastases and Pancreatobiliary Malignancies
Cristina R. Ferrone, MD

10:00 am

10:30 am
Familial Gastrointestinal Cancers: Personalized Strategies for Diagnosis and Management
Sapna Syngal, MD, MPH

11:00 am
Preventing the Development and the Recurrence of Colorectal Cancer through Diet and Lifestyle: Recent and Emerging Clinical Data
Charles S. Fuchs, MD, MPH

11:30 am
Update on the Systemic Therapy for Colorectal Cancer
David P. Ryan, MD

12:00 pm
Case Presentations from the Audience*
Moderator:  Jeffrey W. Clark, MD
Panelists:  All Faculty

*Attendees are encouraged to present their own challenging cases for discussion by our panel of experts.

12:45 pm
Concluding Remarks
Charles S. Fuchs, MD, MPH

1:00 pm

2:00 pm
Meeting Adjourns

Note: Each lecture and case discussion session includes 5-10 minutes for Q&A


Charles S. Fuchs, MD, MPH
Course Director
Director, Gastrointestinal Cancer Center,
Dana-Farber/Brigham and Women’s Cancer Center;
Professor of Medicine,
Harvard Medical School

Jeffrey W. Clark, MD
Director, Clinical Trials Support,
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine,
Harvard Medical School

Peter C. Enzinger, MD
Director, Center for Esophageal and Gastric Cancers,
Dana-Farber/Brigham and Women’s Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School

Cristina R. Ferrone, MD
Surgical Oncologist; Gastrointestinal Surgery,
Massachusetts General Hospital Cancer Center;
Associate Professor of Surgery,
Harvard Medical School

David P. Ryan, MD
Chief, Division of Hematology/Oncology,
Massachusetts General Hospital;
Clinical Director, Massachusetts General Hospital Cancer Center,
Clinical Director, The Tucker Gosnell Center for Gastrointestinal Cancers,
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine,
Harvard Medical School

Sapna Syngal, MD, MPH
Director, Gastrointestinal Cancer Genetics and Prevention Program,
Director, Gastroenterology,
Dana-Farber/Brigham and Women’s Cancer Center;
Associate Professor of Medicine,
Harvard Medical School

Brian M. Wolpin, MD, MPH
Co-Director, Pancreatic Tumor Center,
Dana-Farber/Brigham and Women’s Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School

HMS Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity.  Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

CME Credits

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Registration fee: $50.00 (non-refundable).  Registration fee includes: course materials, continental breakfast, and lunch.

Register Online Now

To register by mail, send completed registration form and check payable to DF/BWCC by January 24, 2014 to:

Gastrointestinal Cancer CME 2014
Dana-Farber/Brigham and Women’s Cancer Center
450 Brookline Avenue, OS 381
Boston, MA 02215
Attn: Kamira Wooten

If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email or call 800-553-3787.

Course Location

This half-day CME course is being held at the Fairmont Copley Plaza Hotel located at 138 St. James Avenue, Boston, MA 02116.

Take The First Step
Make AN Appointment

Boston, Main Campus

Online Appointments

South Shore


Patient Stories

Read inspiring stories of strength,
hope and perseverance.

© 2014; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA